These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19231456)

  • 21. What is the role for surgery in patients with stage III non-small cell lung cancer?
    Vandenbroucke E; De Ryck F; Surmont V; van Meerbeeck JP
    Curr Opin Pulm Med; 2009 Jul; 15(4):295-302. PubMed ID: 19465855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Postoperative chemotherapy in non-small cell lung cancer].
    Milleron B; Gounant V; Giroux-Leprieur E; Lavolé A
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S64-8. PubMed ID: 18235396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of radiotherapy and chemotherapy in locally advanced NSCLC.
    Kepka L; Sprawka A; Casas F; Abdel-Wahab S; Agarwal JP; Jeremic B
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1389-403. PubMed ID: 19827998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basic fibroblast growth factor-2/beta3 integrin expression profile: signature of local progression after chemoradiotherapy for patients with locally advanced non-small-cell lung cancer.
    Massabeau C; Rouquette I; Lauwers-Cances V; Mazières J; Bachaud JM; Armand JP; Delisle MB; Favre G; Toulas C; Cohen-Jonathan-Moyal E
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):696-702. PubMed ID: 19386436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer.
    Yang HX; Hou X; Lin P; Rong TH; Yang H; Fu JH
    Ann Thorac Surg; 2009 Aug; 88(2):372-8. PubMed ID: 19632375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative chemotherapy for n2 non-small-cell lung cancer: conclusions are not black and white, but gray.
    Hanna NH; Einhorn LH
    J Clin Oncol; 2006 Dec; 24(35):5611-2; author reply 5612-3. PubMed ID: 17158549
    [No Abstract]   [Full Text] [Related]  

  • 27. The prognostic impact of main bronchial lymph node involvement in non-small cell lung carcinoma: suggestions for a modification of the staging system.
    Shimada Y; Tsuboi M; Saji H; Miyajima K; Usuda J; Uchida O; Kajiwara N; Ohira T; Hirano T; Kato H; Ikeda N
    Ann Thorac Surg; 2009 Nov; 88(5):1583-8. PubMed ID: 19853116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
    Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
    Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early-stage NSCLC: the role of radiotherapy and systemic therapy.
    Bunn PA
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S31-40. PubMed ID: 19780244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.
    Bellière A; Girard N; Chapet O; Khodri M; Kubas A; Souquet PJ; Mornex F
    Cancer Radiother; 2009 Jul; 13(4):298-304. PubMed ID: 19525134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.
    van Meerbeeck JP; Surmont VF
    Lung Cancer; 2009 Sep; 65(3):257-67. PubMed ID: 19285751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. POINT: Operative risk of pneumonectomy--influence of preoperative induction therapy.
    Gaissert HA; Keum DY; Wright CD; Ancukiewicz M; Monroe E; Donahue DM; Wain JC; Lanuti M; Allan JS; Choi NC; Mathisen DJ
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):289-94. PubMed ID: 19619768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carboplatin-pemetrexed adjuvant chemotherapy in resected non-small cell lung cancer (NSCLC): a phase II study.
    Karapanagiotou EM; Boura PG; Papamichalis G; Konstantinou M; Sepsas E; Chamalakis G; Simsiris P; Gkiozos I; Syrigos KN
    Anticancer Res; 2009 Oct; 29(10):4297-301. PubMed ID: 19846990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Operative risk of pneumonectomy after induction chemoradiotherapy.
    Van Schil PE
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):550. PubMed ID: 17627833
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognosis of stage pIIIA non small cell lung cancer after mediastinal lymph node dissection or sampling.
    Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
    J BUON; 2009; 14(1):45-9. PubMed ID: 19373946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limited resection of non-small cell lung cancer: should brachytherapy be indicated in all cases?
    Sawabata N; Inoue M; Takeda S; Maeda H
    Ann Thorac Surg; 2004 Apr; 77(4):1503-4; author reply 1504. PubMed ID: 15063306
    [No Abstract]   [Full Text] [Related]  

  • 37. Survival of patients with true pathologic stage I non-small cell lung cancer.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of maintenance chemotherapy in advanced nonsmall cell lung cancer.
    Jalal SI; Ademuyiwa FO; Hanna NH
    Curr Opin Oncol; 2009 Mar; 21(2):110-5. PubMed ID: 19532011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary resections for T4 non-small cell lung cancer with support of cardiopulmonary bypass.
    Zieliński M; Kuzdzał J
    Eur J Cardiothorac Surg; 2006 Oct; 30(4):686; author reply 686-7. PubMed ID: 16901710
    [No Abstract]   [Full Text] [Related]  

  • 40. Invited commentary.
    Cerfolio RJ
    Ann Thorac Surg; 2007 Sep; 84(3):958. PubMed ID: 17720407
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.